To determine whether metformin has effect on TGF-β1/smad3 and smad7 expression by inhibiting miR-21 expression in vivo, the expression of TGF-β1/smad3 and smad7 were measured by WB and/or ICC at the end of the study. This evidence concerns the gene SMAD3 and intrahepatic cholangiocarcinoma.